Salud

Mayores de 50 años y gente con males inmunitarios podrán tener cuarta dosis contra covid-19 en EE. UU.

Esta vacuna se administraría cuatro meses después del primer refuerzo; FDA autorizó el uso de emergencia y CDC recomendó su uso

A health worker prepares a dose of the Pfizer-BioNTech vaccine against the coronavirus disease COVID-19 at a vaccination centre in Santiago, on 10 January 2022. - Chile started administering today a fourth COVID-19 vaccine dose to people over the age of 12 with weakened immune systems. (Photo by Javier TORRES / AFP)
A health worker prepares a dose of the Pfizer-BioNTech vaccine against the coronavirus disease COVID-19 at a vaccination centre in Santiago, on 10 January 2022. - Chile started administering today a fourth COVID-19 vaccine dose to people over the age of 12 with weakened immune systems. (Photo by Javier TORRES / AFP) JAVIER TORRES
‌
‌

‌

‌
‌

‌

‌